Nordic Capital Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Nordic Capital has acquired 22 companies. It has also invested in 1 other.

Nordic Capital’s most common sectors for investment are healthcare services (11%) and medical products (10%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (52%) and secondary buyout (28%). In total, Nordic Capital has invested in 8 US states and 13 different countries. Its largest (disclosed) acquisition occurred in 2008 when it acquired ConvaTec for $4.1B.

In the last 3 years, Nordic Capital has exited 4 companies. The Firm’s most common exit type is trade sale (32%). Nordic Capital’s largest (disclosed) exit occurred in 2011 when it sold Nycomed Pharma AG for $10.8B.

Join Mergr to view Nordic Capital’s full profile and discover more mega-sized private equity firms just like it.

M&A Summary

  • M&A Total Activity172
    • M&A Buy Activity111
    • M&A Sell Activity61
  • Total Sectors Invested 33
  • Total Countries Invested 13
  • M&A Buy/Sell Connections 54
  • M&A Advisors 16

Nordic Capital

Mäster Samuelsgatan 21, 9th floor,
Stockholm, SE-111 44
Sweden
+46 8 440 50 50
www.nordiccapital.com
info@nordiccapital.com

Nordic Capital is a private equity investment firm that targets middle-market company investments located in Scandinavia and Northern Europe. Nordic seeks investments across a wide range of industries and prefers situations where there are 'opportunities for new industrial combinations, strategic repositioning, international expansion and operational improvements'. Nordic Capital was formed in 1989 and has offices in Stockholm, Copenhagen, London, Oslo, and Helsinki.


Investment Criteria

Sectors of Interest: Apparel/Textiles, Automotive, Building Materials, Business Services, Chemicals, Communications, Consumer Products, Distribution, Electrical Equipment, Energy Services and Equipment, Environmental, Financial Services, Food, Healthcare Services, Information Technology, Life Science, Machinery, Manufacturing, Marine, Marketing, Medical Products, Metals/Mining, Packaging, Publishing, Retail, Safety/Security, Software, Staffing, Transportation

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Going Private, Secondary Buyout, Stake Purchase

Geographic Preferences: United Kingdom, Western Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue 50 -
Target EBITDA - -
Investment Size - -
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (5.4/yr) # 84 4 7 8 5 3 111
vol $12.4B $355M $846M $13.6B
Sell (1.8/yr) # 52 5 2 1 - 1 61
vol $18.3B $1.7B $744M $258M $20.9B
  172

Most Recent M&A

Company Date Value Type
Sambla AB 2021-02-03 - Buyout (LBO, MBO, MBI)
Stockholm, Sweden · www.sambla.se
Advisa AB 2021-02-03 - Buyout (LBO, MBO, MBI)
Stockholm, Sweden · www.advisa.se
ADVANZ PHARMA Corp. 2021-01-27 846M USD Going Private
London, Ontario · www.advanzpharma.com
Max-Inf Holdings Ltd. 2021-01-11 - Secondary Buyout
Ningbo, China · www.max-inf.com
RegTech 2020-11-04 - Divestiture
Dallas, Texas · www.reg.tech/en/
BearingPoint RegTech 2020-11-04 - Divestiture
Frankfurt, Germany · www.reg.tech
Siteimprove A/S 2020-09-03 - Secondary Buyout
Copenhagen, Denmark · www.siteimprove.com
Max Matthiessen AB 2020-05-25 - Divestiture
Stockholm, Sweden · www.maxm.se
SpaMedica Ltd. 2020-03-17 - Secondary Buyout
Bolton, United Kingdom · www.spamedica.co.uk
Consilium Marine & Safety AB 2019-12-21 355M SEK Divestiture
Hisings Backa, Sweden
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
eResearch Technology, Inc. 2016-03-08 BioClinica, Inc. 2020-12-10 5
Philadelphia, Pennsylvania · www.ert.com Princeton, New Jersey · www.bioclinica.com
Acino International AG 2013-10-02 Takeda Pharmaceutical Co.,Ltd. - Primary Care Portfolio 2019-10-15 4
Zurich, Czech Republic · www.acino.swiss Osaka, Japan
GHD GesundHeits GmbH 2014-06-19 Profusio GesundHeits GmbH Germany 2017-12-19 1
Ahrensburg, Germany · www.gesundheitsgmbh.de Greven, Germany · www.profusio.de
Acino International AG 2013-10-02 Litha Healthcare Group Ltd. 2017-02-28 3
Zurich, Czech Republic · www.acino.swiss Midrand, South Africa · www.lithahealthcare.co.za
Unilabs SA 2007-08-07 Alpha medical a.s. 2017-02-09 2
Geneva, Switzerland · www.unilabs.com Martin, Slovakia · www.alphamedical.sk
eResearch Technology, Inc. 2016-03-08 Exco InTouch Ltd. 2016-12-08 4
Philadelphia, Pennsylvania · www.ert.com Sawbridgeworth, United Kingdom · www.excointouch.com
Acino International AG 2013-10-02 Acino Holding AG - Transdermal Drug Delivery Systems Business 2016-11-30 1
Zurich, Czech Republic · www.acino.swiss Aesch, Czech Republic
Acino International AG 2013-10-02 Norgine - Middle East & North Africa Operations & Product Right 2016-06-28 2
Zurich, Czech Republic · www.acino.swiss , Netherlands
Luvata UK Ltd. 2005-01-01 ECO SpA 2007-05-25 1
London, United Kingdom · www.luvata.com Udine, Italy · www.ecogroup.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 9 (19%) - 12 (11%) 1.9B (14%)
Medical Products 5 (10%) 846M (16%) 10 (9%) 4.9B (36%)
Software 6 (13%) 302M (6%) 7 (6%) 302M (2%)
Manufacturing - - 7 (6%) -
Consumer Products 1 (2%) 719M (14%) 6 (5%) 2.2B (16%)
Life Science 2 (4%) 414M (8%) 6 (5%) 414M (3%)
Business Services 4 (8%) 2.6B (50%) 5 (5%) 2.6B (19%)
Distribution 1 (2%) - 5 (5%) -
Retail 3 (6%) - 5 (5%) -
Financial Services 2 (4%) - 4 (4%) 260M (2%)
Automotive 1 (2%) - 4 (4%) -
Information Technology 2 (4%) - 4 (4%) -
Safety/Security 2 (4%) 355M (7%) 3 (3%) 355M (3%)
Apparel/Textiles 1 (2%) - 3 (3%) 231M (2%)
Consumer Services - - 3 (3%) -
Food 1 (2%) - 3 (3%) -
Internet Software and Services 3 (6%) - 3 (3%) -
Metals/Mining 2 (4%) - 3 (3%) -
E-Commerce 1 (2%) - 2 (2%) 310M (2%)
Marine 1 (2%) - 2 (2%) -
Transportation - - 2 (2%) -
Packaging - - 1 (1%) 140M (1%)
Building Materials - - 1 (1%) -
Chemicals - - 1 (1%) -
Electrical Equipment - - 1 (1%) -
Energy Services and Equipment 1 (2%) - 1 (1%) -
Environmental - - 1 (1%) -
Furniture - - 1 (1%) -
Machinery - - 1 (1%) -
Marketing - - 1 (1%) -
Media - - 1 (1%) -
Publishing - - 1 (1%) -
Staffing - - 1 (1%) -
Total 48 $5.2B 111 $13.6B

Acquisitions By Geo

State/Country Current # Value All-time # Value
Sweden 11 (23%) 355M (7%) 48 (43%) 4.7B (34%)
Denmark 6 (13%) - 12 (11%) -
Norway 6 (13%) 2.9B (55%) 10 (9%) 2.9B (21%)
United States 4 (8%) - 8 (7%) 4.1B (30%)
  Texas 1 (2%) - 1 (1%) -
  Pennsylvania 1 (2%) - 1 (1%) -
  Michigan 1 (2%) - 1 (1%) -
  Florida 1 (2%) - 1 (1%) -
  New Jersey - - 1 (1%) 4.1B (30%)
  Ohio - - 1 (1%) -
  New York - - 1 (1%) -
  Indiana - - 1 (1%) -
Germany 6 (13%) - 7 (6%) -
Switzerland 3 (6%) - 6 (5%) -
United Kingdom 5 (10%) 719M (14%) 5 (5%) 719M (5%)
Finland 2 (4%) - 5 (5%) -
Netherlands 2 (4%) - 4 (4%) -
France 1 (2%) - 3 (3%) -
Canada 1 (2%) 846M (16%) 1 (1%) 846M (6%)
  Ontario 1 (2%) 846M (16%) 1 (1%) 846M (6%)
Czech Republic 1 (2%) 414M (8%) 1 (1%) 414M (3%)
China - - 1 (1%) -
Domestic 11 (23%) 355M (7%) 48 (43%) 4.7B (34%)
Cross-border 37 (77%) 4.9B (93%) 63 (57%) 9.0B (66%)
Total 48 $5.2B 111 $13.6B

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 16 (33%) - 57 (51%) 231M (2%)
Secondary Buyout 21 (44%) 3.6B (69%) 30 (27%) 5.1B (37%)
Divestiture 5 (10%) 355M (7%) 11 (10%) 5.0B (37%)
Going Private 3 (6%) 1.3B (24%) 5 (5%) 3.3B (24%)
Consolidation 1 (2%) - 3 (3%) -
Stake Purchase 1 (2%) - 2 (2%) -
Growth Capital - - 1 (1%) -
PIPE - - 1 (1%) -
Recapitalization 1 (2%) - 1 (1%) -
Total 48 $5.2B 111 $13.6B

Exits by Deal Type

Type Total # Value
Secondary Sale 15 (25%) 3.7B (18%)
IPO 13 (21%) -
Trade Sale - Public Company 12 (20%) 16.3B (78%)
Trade Sale 12 (20%) 976M (5%)
Sold to Management 5 (8%) -
Merger 3 (5%) -
Bankruptcy 1 (2%) -
Total 61 $20.9B

Top M&A Advisors

Financial Deals
Goldman Sachs Investment Banking Division
 3
Moelis & Co.
 2
Carnegie Investment Bank AB
 2
Legal Deals
White & Case LLP
 5
Accura Advokatpartnerselskab
 2
Ashurst LLP
 1

Deal Values

buy # Total
> $1B 4 $10.1B
$100M to $1B 9 $3.6B
TOTAL $13.6B
Largest ConvaTec, Inc.
$4.1B (2008-08-02)
sell # Total
> $1B 5 $16.7B
$100M to $1B 9 $4.2B
< $100M 1 $78M
TOTAL $20.9B
Largest Nycomed Pharma AG
$10.8B (2011-05-19)

M&A Connections

Deals
Acquired from
Investor(s)
26%
29 (26%)
Strategic(s)
9%
10 (9%)
Exited to
Investor(s)
25%
15 (25%)
Strategic(s)
36%
22 (36%)

Investor Summary

Size

Mega

PE Assets

12.5B EUR

Established

1989

Specialist/Generalist

Generalist

Leadership

Morgan Olsson

Co-Founder & Senior Partner

Robert Andreen

Co-founder & Senior Partner

Kristoffer Melinder

Managing Partner

Joakim Karlsson

Senior Partner

Jesper Söderberg

CFO

 Subscribe to unlock this and 161,439
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 150K M&A Transactions
  • 157K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 48K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal